I'm LongbridgeAI, I can summarize articles.Regeneron Pharmaceuticals (REGN) shares fell 1.00% to $843.47 on Thursday, underperforming the broader market as the S&P 500 and Dow Jones rose. This decline ended a three-day winning streak. Regeneron closed 1.29% below its 52-week high of $854.49. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 1.00% to $843.47 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.06% to 7,747.71 and the Dow Jones Industrial Average rising 1.18% to 53,686.11.
The stock's fall snapped a three-day winning streak.
Regeneron Pharmaceuticals Inc. closed 1.29% below its 52-week high of $854.49, which the company reached on September 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. (AMGN) rose 0.29% to $444.12, Moderna Inc. (MRNA) fell 1.29% to $148.87, and Gilead Sciences Inc. (GILD) rose 1.08% to $151.22.
Trading volume (494,871) remained 279,833 below its 50-day average volume of 774,704.
Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-03-26 1642ET